Infleqtion Advances to Phase 3 of Wellcome Leap Q4Bio Challenge for Precision Oncology

Infleqtion, in collaboration with the University of Chicago (UChicago) and the Massachusetts Institute of Technology (MIT), has been selected to advance to Phase 3 of the Wellcome Leap Quantum for Bio (Q4Bio) Challenge. This final stage involves a 12-month validation period supported by $2 million in research funding to transition quantum-enabled biomarker discovery from theoretical […]

The post Infleqtion Advances to Phase 3 of Wellcome Leap Q4Bio Challenge for Precision Oncology appeared first on Quantum Computing Report.